Evaluation of Weekly Paclitaxel, Carboplatin, and Cetuximab in Head and Neck Cancer Patients With Incurable Disease

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2015.12.250
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Phase I and Pharmacokinetic Study of Weekly Paclitaxel and Carboplatin in Patients With Metastatic Esophageal Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

Use of Inpatient Palliative Care Services in Patients With Metastatic Incurable Head and Neck Cancer

Head and Neck
Otorhinolaryngology
2015English

Weekly Docetaxel for Outpatients With Head and Neck Cancer

Japanese jornal of Head and Neck Cancer
2004English

Cetuximab Promotes Epithelial to Mesenchymal Transition and Cancer Associated Fibroblasts in Patients With Head and Neck Cancer

Oncotarget
Oncology
2015English

Efficacy and Toxicity of Weekly Carboplatin and Paclitaxel as Induction or Palliative Treatment in Advanced Esophageal Cancer Patients

Cancers
Cancer ResearchOncology
2019English

Importance of AUC of Carboplatin in Head and Neck Cancer.

Journal of Otolaryngology of Japan
Otorhinolaryngology
1998English

Evaluation of Chemoradiotherapy of Low Dose Carboplatin (CBDCA) for Head and Neck Cancer.

Practica Otologica
Otorhinolaryngology
1995English

Platinum-Based Chemotherapy Plus Cetuximab in Head and Neck Cancer

New England Journal of Medicine
Medicine
2008English

Sensitivity and Specificity of Cetuximab-IRDye800CW to Identify Regional Metastatic Disease in Head and Neck Cancer

Clinical Cancer Research
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy